BiotechTube
Home/Richter Gedeon/Dr. Csaba Sándor
DC

Dr. Csaba Sándor

Head of Manufacturing

Richter Gedeon

Therapeutic Areas

Women's HealthcareCentral Nervous System (CNS)

Richter Gedeon Pipeline

DrugIndicationPhase
Cariprazine (Vraylar)Major Depressive Disorder (adjunctive)Phase III / Filed
Fezolinetant (Veoza)Moderate to Severe Vasomotor Symptoms due to MenopausePhase III / Filed
Biosimilar AdalimumabChronic Inflammatory Diseases (e.g., Rheumatoid Arthritis)Phase III / Filed
Biosimilar DenosumabOsteoporosisPhase III
Novel CNS CompoundUndisclosed CNS DisorderPhase II
Next-gen Women's Health ProductUndisclosed Gynecological ConditionPhase II

Leadership Team at Richter Gedeon

GO
Gábor Orbán
Chief Executive Officer
ZP
Zoltán Papp
Chief Financial Officer
DI
Dr. István Greiner
Head of Research and Development
EB
Erik Bogsch
Executive Director, Head of Commercial Operations
View full Richter Gedeon profile